selected scholarly activity
-
conferences
- Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE). American Heart Journal. 70-80. 2024
- Change in Antiplatelet Therapy in Prevention of Secondary Stroke (CAPS2) Study. Stroke. 2018
- INCIDENCE AND PREDICTORS OF NO REFLOW PHENOMENON: INSIGHTS FROM THE TOTAL TRIAL. Journal of the American College of Cardiology. 1179-1179. 2017
- UTILITY OF UNFRACTIONATED HEPARIN IN TRANSRADIAL CARDIAC CATHETERIZATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED STUDIES. Journal of the American College of Cardiology. 1194-1194. 2017
- Parallel Pilot Screening Frequency Trials In elderly And Nonelderly Critically ill Patients. American Journal of Respiratory and Critical Care Medicine. 2017
- The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention -Insights From the CURRENTOASIS 7 Trial. Circulation. 2016
- Risk Stratification Of The Toronto Ards Cohort Using Recover Program Disability Groups. American Journal of Respiratory and Critical Care Medicine. 2016
- The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial. Circulation. 2269-2270. 2015
- The Optimal Vasopressor Titration (ovation) Pilot Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 2015
- The Recover Program: One-Year Disability In Critically Ill Patients Mechanically Ventilated (mv) For 7 Days. American Journal of Respiratory and Critical Care Medicine. 2015
- Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent. Circulation. 2111-2111. 2014
- TCT- 145 RADIATION PROTECT: A randomized trial to assess the effectiveness of a novel pelvic lead shield and a novel, non-lead surgical cap to reduce operator radiation exposure during coronary angiography or intervention. Journal of the American College of Cardiology. B43-B44. 2014
- A Randomized Trial Of Different Strategies For Introducing Research To Substitute Decision Makers: The Approach Trial (quantitative Study). American Journal of Respiratory and Critical Care Medicine. 2014
- Caregiver Well-Being Is Dependent On Caregiver Mastery, Social Support And Participation In Valued Activities: Towards Recover Study. American Journal of Respiratory and Critical Care Medicine. 2014
- Characteristics And Outcomes Of Eligible Non-Enrolled Patients In The Oscillate Trial. American Journal of Respiratory and Critical Care Medicine. 2014
- Pre-Printed Orders For Thromboprophylaxis In The Icu: A Cross-Sectional Analysis. American Journal of Respiratory and Critical Care Medicine. 2014
- Efficacy and Safety of a Routine Pharmacoinvasive Strategy After Fibrinolysis Stratified by Glycoprotein IIB/IIIA Inhibitor Use: A Pre-Specified Subgroup Analysis of the Transfer-AMI Trial. Canadian Journal of Cardiology. S238-S239. 2013
- Early High-Frequency Oscillation For Adults With Acute Respiratory Distress Syndrome: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 2013
- Long-Term Outcomes After Prolonged Mechanical Ventilation: Family Caregiver Outcomes From The Towards Recover Study. American Journal of Respiratory and Critical Care Medicine. 2013
- Long-Term Patient Outcomes After Prolonged Mechanical Ventilation: The Towards Recover Study. American Journal of Respiratory and Critical Care Medicine. 2013
- 427 Providing a Platform for Organized Care in ST Elevation Myocardial Infarction: The LHIN-4 SMART-AMI Project in Southern Ontario Experience. Canadian Journal of Cardiology. S259-S260. 2012
- Cardiac troponin T concentrations 30days post myocardial infarction: Results of a small prospective observational study. Clinical Biochemistry. 1119-1119. 2012
- 248 Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: A subgroup analysis from TRANSFER-AMI. Canadian Journal of Cardiology. S152-S153. 2011
- Initial Ventilatory Parameters For High Frequency Oscillation In A Pilot RCT Compared With Recent Historical Controls. American Journal of Respiratory and Critical Care Medicine. 2011
- Long-Term Outcomes After Prolonged Mechanical Ventilation: The Towards Recover Study. American Journal of Respiratory and Critical Care Medicine. 2011
- Long-Term Outcomes After Prolonged Mechanical Ventilation: Family Caregiver Outcomes From The Towards Recover Study. American Journal of Respiratory and Critical Care Medicine. 2011
- Long-Term Outcomes After Prolonged Mechanical Ventilation: The Towards Recover Study. American Journal of Respiratory and Critical Care Medicine. 2011
- EFFICACY AND SAFETY OF CLOPIDOGREL COMPARED WITH PLACEBO ACCORDING TO CYP2C19 GENOTYPE IN OVER 6000 PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES (CURE TRIAL) AND ATRIAL FIBRILLATION (ACTIVE TRIAL). Canadian Journal of Cardiology. 146D-146D. 2010
- FONDAPARINUX WITH UNFRACTIONATED HEPARIN DURING REVASCULARISATION IN ACUTE CORONARY SYNDROMES (FUTURA/OASIS 8): A RANDOMISED TRIAL EVALUATING THE SAFETY OF TWO REGIMENS OF ADJUNCTIVE INTRAVENOUS UNFRACTIONATED HEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES INITIALLY TREATED WITH SUBCUTANEOUS FONDAPARINUX. Canadian Journal of Cardiology. 147D-147D. 2010
- REPERFUSION THERAPY IN STEMI: DO LATE PRESENTATION PATIENTS (=12 HOURS) DERIVE CLINICAL BENEFIT?. Canadian Journal of Cardiology. 106D-106D. 2010
- Clinical Practice Guidelines (CPGs) for Mask CPAP (CPAP) and Noninvasive Ventilation (NIV) in Acute Care Settings.. American Journal of Respiratory and Critical Care Medicine. 2009
- SLEAP: A Multicenter Randomized Trial of Daily Awakening in Critically Ill Patients Being Managed with a Sedation Protocol.. American Journal of Respiratory and Critical Care Medicine. 2009
- Troponin and CKMB Trends in Patients with Septic Shock Randomized to Vasopressin (VP) or Norepinephrine (NE).. American Journal of Respiratory and Critical Care Medicine. 2009
- Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction. Journal of the American College of Cardiology. A467-A467. 2009
- A Multicentre Pilot Randomized Trial of High Frequency Oscillation in Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 2009
- A Prospective Evaluation of Sedative, Analgesic, Anti-Psychotic and Paralytic Practices in Canadian Mechanically Ventilated Adults. American Journal of Respiratory and Critical Care Medicine. 2009
- Adjudication Calibration for Pulmonary Embolism in a Thromboprophylaxis Trial. American Journal of Respiratory and Critical Care Medicine. 2009
- Conversion from Ventilation to High Frequency Oscillation - Physiologic Responses in a Pilot Randomized Trial.. American Journal of Respiratory and Critical Care Medicine. 2009
- Current High Frequency Oscillation (HFO) Utilization in Ontario.. American Journal of Respiratory and Critical Care Medicine. 2009
- Efficacy and Safety of Clopidogrel in Acute Coronary Syndrome Patients at High Risk of Bleeding: Data from the CURE Trial. Circulation. S916-S916. 2008
- Paradoxical Low Use of Coronary interventions in High-Risk Non-st Segment Acute Coronary Syndromes with Heart Failure. Data from the Oasis-5 Randomized Trial. Circulation. S975-S976. 2008
- Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) - Six Month Outcomes. Circulation. S1075-S1076. 2008
- Anticoagulant intensity of enoxaparin compared with fondaparinux in the OASIS-5 trial. European Heart Journal. 746-746. 2008
- Fondaparinux administration according to its European labeling improves outcome in patients with ST elevation acute myocardial infarction (STEMI): a subanalysis of the OASIS-6 study. European Heart Journal. 329-329. 2008
- Long-term net clinical benefit in favor of fondaparinux compared with enoxaparin in European patients with non-ST elevation acute coronary syndromes: a subgroup analysis of OASIS-5. European Heart Journal. 327-328. 2008
- Cardiovascular fitness and cognition in mild-moderate Parkinson's disease. Neurology. A290-A290. 2008
- Elevated in-hospital glucose level, and not known history of diabetes mellitus, predicts 30-day mortality following acute ST-elevation myocardial infarction. Circulation. 824-824. 2007
- The relative safety and efficacy of clopidogrel in women and men: Meta-analysis of 79,613 patients enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA. Circulation. 483-483. 2007
- Bleeding risk of glycoprotein (GP) IIB IIIA inhibitors or thienopyridines with fondaparinux vs enoxaparin in acute coronary syndromes: Insights from the oasis 5 trial. Canadian Journal of Cardiology. 223C-223C. 2007
- The effect of duration of therapy on the benefit of fondaparinux over enoxaparin in acute coronary syndromes: Insights from the OASIS 5 trial. Canadian Journal of Cardiology. 121C-122C. 2007
- Bleeding risk of Glycoprotein (GP) IIb IIIa inhibitors or thienopyridines with fondaparinux vs. enoxaparin in Acute Coronary Syndromes: insights from the OASIS 5 trial. European Heart Journal. 516-516. 2007
- Contemporary therapies for diabetes in the cardiovascular populations of the US and Europe. European Heart Journal. 458-458. 2007
- Cost-effectiveness in France of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome: an analysis using data from OASIS-5. European Heart Journal. 858-858. 2007
- The effect of duration of therapy on the benefit of fondaparinux over enoxaparin in acute coronary syndromes: insights from the OASIS 5 trial. European Heart Journal. 187-187. 2007
- Tracking JNC 7: trends in blood pressure and anti-hypertensive treatments in the US. European Heart Journal. 871-871. 2007
- Effects of aspirin dose on ischemic events and bleeding after percutaneous coronary intervention: Insights from the PCI-CURE study. Journal of the American College of Cardiology. 46B-46B. 2007
- Efficacy and safety of fonclaparinux in elderly patients with ST segment elevation myocardial infarction: Data from the OASIS 6 trial. Journal of the American College of Cardiology. 242A-242A. 2007
- Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment. Circulation. 699-700. 2006
- Fondaparinux versus control (placebo or unfractionated heparin) as an adjunct to thrombolytic therapy in acute myocardial infarction: an OASIS 6 substudy. Circulation. 699-699. 2006
- Major bleeding in patients with acute coronary syndrome undergoing early invasive management can be reduced by fondaparinux, even in the context of trans-radial coronary intervention: Insights from OASIS-5 trial. Circulation. 552-552. 2006
- Benefit of clopidogrel pretreatment before PCI regardless of GP IIb/IIIa inhibitor use. European Heart Journal. 862-862. 2006
- Fondaparinux results in less bleeding than enoxaparin, irrespective of heparin use, for patients with acute coronary syndromes. European Heart Journal. 448-448. 2006
- International comparisons of the prevalence of obesity in patients with overt cardiovascular disease. European Heart Journal. 238-238. 2006
- International trends in reaching therapeutic goals for hypertension in diabetics. European Heart Journal. 105-106. 2006
- Relationship of baseline hemoglobin levels with short term outcome in acute coronary syndromes. Insights from the OASIS 5 and 6 trials. European Heart Journal. 160-160. 2006
- Bleeding complications predict major cardiovascular outcomes in non ST-elevation acute coronary syndromes: Results from the OASIS-5 trial. Journal of the American College of Cardiology. 195A-195A. 2006
- Fondaparinux is associated with substantially less major bleeding and vascular access site complications compared with enoxaparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the OASIS 5 trial. Journal of the American College of Cardiology. 205A-205A. 2006
- Fondaparinux versus enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Impact of risk according to the GRACE score. Journal of the American College of Cardiology. 223A-223A. 2006
- The efficacy and safety of fondaparinux versus enoxaparin in non-ST elevation ACS: Impact of renal dysfunction (OASIS 5). Journal of the American College of Cardiology. 195A-195A. 2006
- Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: A meta-analysis of the randomized trials. Journal of the American College of Cardiology. 228A-229A. 2006
- A randomised blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: the ASPIRE pilot study. European Heart Journal. 482-482. 2005
- Impact of glucose-insulin-potassium on mortality and morbidity in over 20,000 patients with acute myocardial infarction: The CREATE-ECLA international trial. Circulation. 1725-1726. 2005
- Baseline high-sensitivity C-reactive protein offers prognostic value in addition to contemporary risk stratification in non-ST-segment elevation acute coronary syndrome: Results from the CURE inflammatory marker substudy. Circulation. 499-499. 2004
- 1098-79 Renal function predicts outcomes in acute coronary syndromes: Insights from the CURE trial. Journal of the American College of Cardiology. A278-A278. 2004
- 1137-77 Long-term cost-effectiveness of clopidogrel in patients having percutaneous coronary intervention early after acute coronary syndrome: Results from PCI-CURE. Journal of the American College of Cardiology. A296-A296. 2004
- Long-term cost effectiveness of platelet inhibition with clopidogrel in patients undergoing PCI after presenting with an acute coronary syndrome: Results from PCI-CURE. Circulation. 576-576. 2003
- Benefit of clopidogrel in patients undergoing percutaneous coronary intervention in the CURE trial receiving and not receiving an intracoronary Stent. Journal of the American College of Cardiology. 45A-45A. 2003
- Incremental cost-effectiveness of early and long-term clopidogrel in patients undergoing percutaneous coronary infarction in the CURE trial: The PCI-CURE economic analysis. Journal of the American College of Cardiology. 383A-383A. 2003
- Randomized comparison of dalteparin versus unfractionated heparin during percutaneous coronary interventions. Journal of the American College of Cardiology. 68A-69A. 2003
- 2047 Consistent benefit of clopidogrel in patients with non-ST-elevation acute coronary syndromes undergoing very early, early or later percutaneous coronary intervention in the CURE study. European Heart Journal. 377-377. 2003
- Benefit of Clopidogrel in patients with acute coronary syndromes without ST-segment elevation (ACS) in various risk groups. Circulation. 455-455. 2002
- Rapid emergence of benefit with clopidogrel followed by incremental reduction in major cardiovascular events with long term therapy after acute coronary syndrome: Insights from the CURE trial. Circulation. 493-493. 2002
- The risks versus benefits of clopidogrel treatment in acute coronary syndrome patients overall, and those undergoing CABG: the CURE trial. European Heart Journal. 510-510. 2002
- Long-term management of unstable angina and non-Q-wave myocardial infarction. European Heart Journal, Supplement. E6-E12. 2000
- Substantial benefit of hirudin compared to heparin among unstable angina patients undergoing early percutaneous coronary intervention. Journal of the American College of Cardiology. 357A-357A. 2000
- Impact of a history of heart failure on outcome in patients with acute coronary syndromes: An analysis from the OASIS registry. Circulation. 641-641. 1999
- Increased morbidity and mortality in diabetic patients with acute myocardial infarction is not explained by larger infarct size or poorer left ventricular systolic dysfunction: insights from the CORE study.. Circulation. 640-640. 1999
- Invasive versus conservative management of unstable angina and non-Q-wave infarction: A meta-analysis. Circulation. 775-775. 1999
- High frequency oscillatory ventilation (HFOV) in adults with ARDS.. American Journal of Respiratory and Critical Care Medicine. A49-A49. 1999
- The Ankle Brachial Index Independently Predicts Walking Velocity and Walking Endurance in Peripheral Arterial Disease. Journal of The American Geriatrics Society. 1355-1362. 1998
-
journal articles
- The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey. Canadian Journal of Cardiology. 38:S79-S88. 2022
- Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention. Current Cardiology Reports. 24:277-293. 2022
- Evaluation of Immature Granulocyte Count as the Earliest Biomarker for Sepsis. Indian Journal of Critical Care Medicine. 26:216-223. 2022
- Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease. Heart. 107:1739-1747. 2021
- Brain autopsies in fatal COVID-19 and postulated pathophysiology: more puzzling than a Rubik’s cube. Journal of Clinical Pathology - Clinical Molecular Pathology. 74:612-613. 2021
- Cautious interpretation of antiphospholipid antibodies in COVID-19. Clinica Chimica Acta. 509:166-166. 2020
- Complete or Incomplete Revascularization for ST-Segment Elevation Myocardial Infarction. Interventional Cardiology Clinics. 9:433-440. 2020
- Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?. Journal of Global Antimicrobial Resistance. 22:864-865. 2020
- Acute Coronary Syndromes and Multivessel Disease. JACC: Cardiovascular Interventions. 13:1568-1570. 2020
- RDW & RBC Histogram — All that Physicians should Know & Apply in Clinical Practice. Journal of the Indian Medical Association. 118:18-23. 2020
- A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia.. The Journal of the Association of Physicians of India. 68:39-41. 2020
- Complete Revascularization with Multivessel PCI for Myocardial Infarction. New England Journal of Medicine. 382:1568-1572. 2020
- Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 74:2713-2723. 2019
- Low Dose Prophylaxis vis-a-vis on-Demand Treatment Strategies for Hemophilia: A Cost Effective and Disability Attenuating Approach.. The Journal of the Association of Physicians of India. 67:52-55. 2019
- Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction. American Heart Journal. 215:157-166. 2019
- Culprit-Only Versus Complete Coronary Revascularization After ST-Segment Elevation Myocardial Infarction- A Systematic Review and Analysis of Clinical Outcomes. Journal of Cardiothoracic and Vascular Anesthesia. 33:850-857. 2019
- Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns. Catheterization and Cardiovascular Interventions. 92:854-859. 2018
- Nonculprit Lesion Intervention. JACC: Cardiovascular Interventions. 11:2274-2275. 2018
- The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry. Catheterization and Cardiovascular Interventions. 92:E356-E367. 2018
- Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial. Journal of the American College of Cardiology. 72:1589-1596. 2018
- Varying Effects of Body Mass Index and Mortality in Different Risk Groups. American Journal of Cardiology. 122:1155-1160. 2018
- Assessment of Pituitary Gonadal Axis and Sperm Parameters in Anemic Eugonadal Males Before and After Correction of Iron Deficiency Anemia.. The Journal of the Association of Physicians of India. 66:11-12. 2018
- Assessment of pituitary gonadal axis and sperm parameters in anemic eugonadal males before and after correction of iron deficiency anemia. The Journal of the Association of Physicians of India. 66:41-44. 2018
- High-sensitivity cardiac troponin concentrations at emergency department presentation in females and males with an acute cardiac outcome. Annals of Clinical Biochemistry. 55:604-607. 2018
- Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department. CANADIAN MEDICAL ASSOCIATION JOURNAL. 190:E974-E984. 2018
- Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors. Circulation: Cardiovascular Interventions. 11:e006084. 2018
- Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Canadian Journal of Cardiology. 34:736-743. 2018
- Incidence of thrombosis in perioperative and non-operative myocardial infarction. British Journal of Anaesthesia. 120:725-733. 2018
- Performance of high-sensitivity cardiac troponin in the emergency department for myocardial infarction and a composite cardiac outcome across different estimated glomerular filtration rates. Clinica Chimica Acta. 479:166-170. 2018
- Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital. CANADIAN MEDICAL ASSOCIATION JOURNAL. 190:E347-E354. 2018
- 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. Canadian Journal of Cardiology. 34:214-233. 2018
- Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT). Clinical Cardiology. 41:285-292. 2018
- Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI. Journal of Thrombosis and Thrombolysis. 45:225-233. 2018
- Identifying and Treating Young Patients at Risk for Cardiovascular Events. Journal of the American College of Cardiology. 71:303-305. 2018
- Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Critical Care. 21:98. 2017
- Timing of Angiography and Outcomes in High-Risk Patients With Non–ST-Segment–Elevation Myocardial Infarction Managed Invasively. Circulation. 136:1895-1907. 2017
- Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association. 6:e006577. 2017
- Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes. American Journal of Cardiology. 120:1453-1459. 2017
- Reperfusion strategies in acute myocardial infarction and multivessel disease. Nature Reviews Cardiology. 14:665-678. 2017
- Subclinical Atrial Fibrillation in Older Patients. Circulation. 136:1276-1283. 2017
- Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study. European Heart Journal - Quality of Care and Clinical Outcomes. 3:qcw051-qcw051. 2017
- Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI. American Heart Journal. 192:105-112. 2017
- Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology. 33:1245-1253. 2017
- MitraClip and Transcatheter Aortic Valve Replacement in a Patient With Recurrent Heart Failure. Circulation: Cardiovascular Interventions. 10:e005312. 2017
- Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel disease. Current Opinion in Cardiology. 32:600-607. 2017
- P2Y12 receptor inhibitor resistance and coronary artery disease. Current Opinion in Cardiology. 32:617-626. 2017
- Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. The Lancet. 390:737-746. 2017
- High-Sensitivity Cardiac Troponin Risk Cutoffs for Acute Cardiac Outcomes at Emergency Department Presentation. Canadian Journal of Cardiology. 33:898-903. 2017
- A laboratory score at presentation to rule-out serious cardiac outcomes or death in patients presenting with symptoms suggestive of acute coronary syndrome. Clinica Chimica Acta. 469:69-74. 2017
- Nonculprit Vessel Intervention: Let's COMPLETE the Evidence. Revista española de cardiología (English ed.). 70:418-420. 2017
- SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal. 38:1147-1155. 2017
- Smokers and Postcessation Weight Gain After Acute Coronary Syndrome. Journal of the American Heart Association. 6:e004785. 2017
- Multivessel Revascularization and ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions. 10:e005215. 2017
- After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding. ACP journal club. 166:JC29-JC29. 2017
- Economic Considerations of Early Rule-In/Rule-Out Algorithms for The Diagnosis of Myocardial Infarction in The Emergency Department Using Cardiac Troponin and Glycemic Biomarkers. Clinical Chemistry. 63:593-602. 2017
- Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy. International Journal of Cardiology. 228:459-464. 2017
- Rule-In and Rule-Out of Myocardial Infarction Using Cardiac Troponin and Glycemic Biomarkers in Patients with Symptoms Suggestive of Acute Coronary Syndrome. Clinical Chemistry. 63:403-414. 2017
- Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. American Heart Journal. 182:125-134. 2016
- A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. Canadian Journal of Cardiology. 32:1332-1339. 2016
- Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT). American Heart Journal. 181:26-34. 2016
- Ethnic differences in case fatality following an acute ischaemic heart disease event in New Zealand: ANZACS-QI 13. European Journal of Preventive Cardiology (EJPC). 23:1823-1830. 2016
- Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”. Circulation. 134:e334-e335. 2016
- Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy. American Heart Journal. 180:82-89. 2016
- Participation Rates With Opt-out Enrollment in a Remote Monitoring Intervention for Patients With Myocardial Infarction. JAMA cardiology. 1:847-847. 2016
- Pulmonary hypertension: diagnostic approach and optimal management. CANADIAN MEDICAL ASSOCIATION JOURNAL. 188:804-812. 2016
- Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention. Circulation. 133:2094-2098. 2016
- Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Medicine. 42:542-550. 2016
- Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome. Circulation. 133:21-30. 2016
- Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. The Lancet. 387:127-135. 2016
- Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial. American Heart Journal. 170:880-886. 2015
- Randomized Controlled Trial of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap for Operators Performing Coronary Angiography or Intervention. Circulation: Cardiovascular Interventions. 8:e002384. 2015
- Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial. American Heart Journal. 170:110-116. 2015
- Coronary intervention: radial artery access comes of age. The Lancet. 385:2437-2439. 2015
- Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non–ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions. 8:e002044. 2015
- Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent. Circulation: Cardiovascular Interventions. 8:e002372. 2015
- Efficacy and Safety of a Routine Early Invasive Strategy in Relation to Time from Symptom Onset to Fibrinolysis (a Subgroup Analysis of TRANSFER-AMI). American Journal of Cardiology. 115:1005-1012. 2015
- Radial Versus Femoral Access for Coronary Angiography/Intervention in Women With Acute Coronary Syndromes. JACC: Cardiovascular Interventions. 8:505-512. 2015
- Cost Implication of an Early Invasive Strategy on Weekdays and Weekends in Patients With Acute Coronary Syndromes. Canadian Journal of Cardiology. 31:314-319. 2015
- Providing optimal regional care for ST-segment elevation myocardial infarction: a prospective cohort study of patients in the Hamilton Niagara Haldimand Brant Local Health Integration Network. CMAJ open. 3:E1-E7. 2015
- Comparison of the Efficacy of Pharmacoinvasive Management for ST-Segment Elevation Myocardial Infarction in Smokers Versus Non-Smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction). American Journal of Cardiology. 114:955-961. 2014
- Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. European Heart Journal. 35:2516-2523. 2014
- Riociguat: A Novel Therapeutic Option for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Canadian Journal of Cardiology. 30:1233-1240. 2014
- Association of cyclooxygenase-2 genetic variant with cardiovascular disease. European Heart Journal. 35:2242-2248. 2014
- Helex device closure of multiple atrial septal defects. Catheterization and Cardiovascular Interventions. 84:204-210. 2014
- The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. Journal of Nuclear Cardiology. 21:739-746. 2014
- Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial. Heart. 100:873-880. 2014
- Incremental Value of Left Ventricular Systolic and Diastolic Function to Determine Outcome in Patients with Acute ST‐Segment Elevation Myocardial Infarction: The Echocardiographic Substudy of the OASIS‐6 Trial. Echocardiography. 31:569-578. 2014
- A Tale of Two Cities: STEMI Interventions in Developed and Developing Countries and the Potential of Telemedicine to Reduce Disparities in Care. Journal of Interventional Cardiology. 27:155-166. 2014
- Procedural Volume and Outcomes With Radial or Femoral Access for Coronary Angiography and Intervention. Journal of the American College of Cardiology. 63:954-963. 2014
- Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16. European Journal of Preventive Cardiology (EJPC). 21:192-202. 2014
- Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A systematic review and meta-analysis. American Heart Journal. 167:1-14.e2. 2014
- A Classically Enlarged Cardiac Silhouette. American Journal of Medicine. 126:e5-e6. 2013
- Cangrelor: a new CHAMPION for percutaneous coronary intervention. The Lancet. 382:1960-1962. 2013
- Treatment Goals of Pulmonary Hypertension. Journal of the American College of Cardiology. 62:D73-D81. 2013
- Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy. Canadian Journal of Cardiology. 29:1334-1345. 2013
- Secretory Phospholipase A2-IIA and Cardiovascular Disease. Journal of the American College of Cardiology. 62:1966-1976. 2013
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes. Journal of the American Medical Association (JAMA). 310:1145-1145. 2013
- Right Ventricular Tachycardia. Circulation. 128:e85-e87. 2013
- Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non‐ST‐Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study (SWITCH III). Journal of Interventional Cardiology. 26:107-113. 2013
- Clinical outcomes and cost implications of routine early PCI after fibrinolysis: One-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study. American Heart Journal. 165:630-637.e2. 2013
- Perrault Syndrome Is Caused by Recessive Mutations in CLPP, Encoding a Mitochondrial ATP-Dependent Chambered Protease. American Journal of Human Genetics. 92:605-613. 2013
- Effect of Radial Versus Femoral Access on Radiation Dose and the Importance of Procedural Volume. JACC: Cardiovascular Interventions. 6:258-266. 2013
- How Should We Treat Multi-Vessel Disease in STEMI Patients?. Current Treatment Options in Cardiovascular Medicine. 15:129-136. 2013
- Persistent Increases in Cardiac Troponin Concentrations As Measured with High-Sensitivity Assays after Acute Myocardial Infarction. Clinical Chemistry. 59:443-445. 2013
- Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy. American Heart Journal. 164:817-824.e13. 2012
- Effects of Radial Versus Femoral Artery Access in Patients With Acute Coronary Syndromes With or Without ST-Segment Elevation. Journal of the American College of Cardiology. 60:2490-2499. 2012
- Warfarin After Bioprosthetic Aortic Valve Implantation. Journal of the American Medical Association (JAMA). 308:2147-2147. 2012
- Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin. Journal of Thrombosis and Thrombolysis. 34:429-436. 2012
- Compulsive Thrombus Management in STEMI Interventions. Interventional Cardiology Clinics. 1:485-505. 2012
- Door-to-Balloon ST-Elevation Myocardial Infarction Interventions. Interventional Cardiology Clinics. 1:521-557. 2012
- Global Acute Myocardial Infarction Perspectives. Interventional Cardiology Clinics. 1:479-484. 2012
- Optimal Anticoagulant Therapy in ST Elevation Myocardial Infarction Interventions. Interventional Cardiology Clinics. 1:421-428. 2012
- Reduced cardiac output and its correlation with coronary blood flow and troponin in asphyxiated infants treated with therapeutic hypothermia. European Journal of Pediatrics. 171:1511-1517. 2012
- STEMI Interventions. Interventional Cardiology Clinics. 1:xiii-xiv. 2012
- Telemedicine. Interventional Cardiology Clinics. 1:623-629. 2012
- Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: A subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). American Heart Journal. 164:343-350. 2012
- The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. European Heart Journal. 33:2143-2150. 2012
- Authors' reply to “Could radial instead of femoral access for coronary angiography change renal outcome? Nephrologists call for help”. American Heart Journal. 163:e21-e21. 2012
- Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events. Circulation. Genomic and precision medicine. 5:250-256. 2012
- Rethinking QRS Duration as an Indication for CRT. Journal of Cardiovascular Electrophysiology. 23:169-171. 2012
- Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. European Heart Journal. 33:51-60. 2012
- Systems of care for ST-elevation myocardial infarction in India. Heart. 98:15-17. 2012
- Target-Controlled Dosing of Remifentanil During Cardiac Surgery Reduces Postoperative Hyperalgesia. Journal of Cardiothoracic and Vascular Anesthesia. 25:917-925. 2011
- Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment Elevation ACS. Canadian Journal of Cardiology. 27:S387-S401. 2011
- Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation Myocardial Infarction. Canadian Journal of Cardiology. 27:S402-S412. 2011
- RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. European Heart Journal. 32:2541-2554. 2011
- Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes. European Heart Journal. 32:2256-2265. 2011
- Long-term benefit using DES in STEMI patients.. Journal of Invasive Cardiology. 23:342. 2011
- Radial versus femoral access in acute coronary syndromes – Authors' reply. The Lancet. 378:661-662. 2011
- Reply. JACC: Cardiovascular Interventions. 4:937-938. 2011
- Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes. EuroIntervention. 7:91-97. 2011
- Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. The Lancet. 377:1409-1420. 2011
- Radial Artery Access as a Predictor of Increased Radiation Exposure During a Diagnostic Cardiac Catheterization Procedure. JACC: Cardiovascular Interventions. 4:347-352. 2011
- Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. American Heart Journal. 161:254-260.e4. 2011
- Clopidogrel in acute coronary syndromes: Where are we now?. Thrombosis and Haemostasis. 105:766-773. 2011
- Hepcidin in anemia of chronic heart failure. American Journal of Hematology. 86:107-109. 2011
- Dosing of Clopidogrel and Aspirin in Acute Coronary Syndromes REPLY. New England Journal of Medicine. 363:2467-2468. 2010
- Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. American Heart Journal. 160:1049-1055. 2010
- Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux. American Heart Journal. 160:1029-1034.e1. 2010
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. The Lancet. 376:1233-1243. 2010
- Panel summary and recommendations on the role of thrombectomy with primary PCI for STEMI.. Journal of Invasive Cardiology. 22:34B-35B. 2010
- Selective strategy for thrombus management in STEMI interventions.. Journal of Invasive Cardiology. 22:26B-33B. 2010
- Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial. Journal of the American Medical Association (JAMA). 304:1339-1349. 2010
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes. New England Journal of Medicine. 363:930-942. 2010
- Response to Letter Regarding Article, “Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction”. Circulation. 122:E397-E397. 2010
- Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet?. Current Cardiology Reports. 12:344-347. 2010
- QT Prolongation Is an Independent Predictor of Mortality in End‐Stage Renal Disease. Clinical Cardiology. 33:361-366. 2010
- Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents. Circulation. 121:2067-2070. 2010
- Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. Medical Journal of Australia. 192:487-488. 2010
- Hemoptysis caused by erosion of thoracic aortic aneurysm. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:E186-E186. 2010
- Adjunct Therapy in STEMI Intervention. Cardiology Clinics. 28:107-125. 2010
- Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial. Journal of Thrombosis and Haemostasis. 8:243-249. 2010
- Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. European Heart Journal. 31:50-58. 2010
- Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction. Circulation. 120:2429-2437. 2009
- Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience. American Heart Journal. 158:917-924. 2009
- The Relative Efficacy and Safety of Clopidogrel in Women and Men. Journal of the American College of Cardiology. 54:1935-1945. 2009
- Myocardial salvage beyond recanalization of the STEMI lesion.. Journal of Invasive Cardiology. 21:456. 2009
- Acute Coronary Syndromes REPLY. New England Journal of Medicine. 361:926-927. 2009
- Early revascularization for cardiogenic shock in the elderly - has the moment of doubt passed?. Journal of Invasive Cardiology. 21:312-313. 2009
- Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines. Journal of the American College of Cardiology. 54:468-476. 2009
- Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. New England Journal of Medicine. 360:2705-2718. 2009
- Genomic and Genic Deletions of the FOX Gene Cluster on 16q24.1 and Inactivating Mutations of FOXF1 Cause Alveolar Capillary Dysplasia and Other Malformations. American Journal of Human Genetics. 84:780-791. 2009
- Early versus Delayed Invasive Intervention in Acute Coronary Syndromes. New England Journal of Medicine. 360:2165-2175. 2009
- Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. American Heart Journal. 157:845-852. 2009
- Role of first-drawn indeterminate troponin-I levels in the Emergency Department. International Journal of Cardiology. 134:417-418. 2009
- Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. European Heart Journal. 30:900-907. 2009
- Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. American Heart Journal. 157:763-770. 2009
- Aspirin for Prevention and Treatment of Cardiovascular Disease. ACP journal club. 150:414-414. 2009
- Community Based Parasitic Screening and Treatment of Sudanese Refugees: Application and Assessment of Centers for Disease Control Guidelines. American Journal of Tropical Medicine and Hygiene. 80:425-430. 2009
- Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: A qualitative systematic review. Canadian Journal of Cardiology. 25:e63-e68. 2009
- Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk. American Heart Journal. 157:502-508. 2009
- Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6. Expert Review of Cardiovascular Therapy. 7:241-249. 2009
- Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. European Heart Journal. 30:655-661. 2009
- Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. American Heart Journal. 157:132-140. 2009
- Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy. American Heart Journal. 156:1080-1088.e1. 2008
- Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes. Circulation. 118:2038-2046. 2008
- Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. American Heart Journal. 156:719-727. 2008
- Glucose-Insulin-Potassium Therapy in Patients With STEMI—Reply. Journal of the American Medical Association (JAMA). 299:2385-2385. 2008
- Computed tomographic coronary angiographic assessment of high-risk coronary anatomy in patients with suspected coronary artery disease and intermediate pretest probability. American Heart Journal. 155:918-923. 2008
- Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use. American Heart Journal. 155:910-917. 2008
- Focus: STEMI interventions. Heralding a new era in the management of STEMI interventions: optimizing the process and the procedure.. Journal of Invasive Cardiology. 20:A5-A6. 2008
- Clinical benefit and practical use of fondaparinux in the invasive management of patients with acute coronary syndromes. European Heart Journal, Supplement. 10:C14-C21. 2008
- Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. European Heart Journal. 29:315-323. 2008
- The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. European Heart Journal. 29:324-331. 2008
- Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). American Heart Journal. 155:19-25. 2008
- Rationale and design of the trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infarction (TRANSFER-AMI). American Heart Journal. 155:19-25. 2008
- Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American Medical Association (JAMA). 298:2399-2399. 2007
- Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial. Canadian Journal of Cardiology. 23:1037-1042. 2007
- Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 50:1742-1751. 2007
- Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes. ACP journal club. 147:304-304. 2007
- Acute coronary syndromes without ST segment elevation. The BMJ. 334:1265-1269. 2007
- An Annual, Prospective, International Study of Outpatients With Cardiovascular Disease or Risk Factors. Critical Pathways in Cardiology. 6:72-75. 2007
- Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. European Journal of Preventive Cardiology (EJPC). 14:312-318. 2007
- Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). Vascular Health and Risk Management. 2:379-387. 2006
- Fondaparinux in Patients With ST-Segment Elevation Myocardial Infarction—Reply. Journal of the American Medical Association (JAMA). 296:2087-2087. 2006
- Clopidogrel in non-ST-segment elevation acute coronary syndromes. European Heart Journal, Supplement. 8:G25-G30. 2006
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes. Circulation. 114:774-782. 2006
- Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 114:774-782. 2006
- Fondaparinux versus enoxaparin in acute coronary syndromes - Reply. New England Journal of Medicine. 354:2830-2830. 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. New England Journal of Medicine. 354:1464-1476. 2006
- Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial. Journal of the American Medical Association (JAMA). 295:1519-1530. 2006
- A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions. American Heart Journal. 151:175.e1-175.e6. 2006
- Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation. American Heart Journal. 151:219-227. 2006
- Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction. Circulation. 112:3855-3867. 2005
- Routine vs Selective Invasive Strategies in Acute Coronary Syndromes—Reply. Journal of the American Medical Association (JAMA). 294:2844-2844. 2005
- Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. American Heart Journal. 150:1177-1184. 2005
- Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes. American Heart Journal. 150:1107.e1-1107.e10. 2005
- Differences in the Management and Prognosis of Women and Men Who Suffer From Acute Coronary Syndromes. Journal of the American College of Cardiology. 46:1845-1851. 2005
- Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. European Heart Journal. 26:2396-2403. 2005
- Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension.. Canadian Journal of Cardiology. 21:909-914. 2005
- Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes. Journal of the American Medical Association (JAMA). 293:2908-2908. 2005
- Glucose-Insulin-Potassium Infusion and Mortality in the CREATE-ECLA Trial—Reply. Journal of the American Medical Association (JAMA). 293:2596-2596. 2005
- Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.. Journal of Invasive Cardiology. 17:283-287. 2005
- Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention. Circulation. 111:1390-1397. 2005
- Effects of Retinoic Acid on Retinal Pigment Epithelium from Excised Membranes from Proliferative Vitreoretinopathy. Journal of Ocular Pharmacology and Therapeutics. 21:44-54. 2005
- Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction. Journal of the American Medical Association (JAMA). 293:437-437. 2005
- Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation. Journal of the American Medical Association (JAMA). 293:427-427. 2005
- Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes. Canadian Journal of Physiology and Pharmacology. 83:98-103. 2005
- Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction. American Heart Journal. 148:1068-1078. 2004
- Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome. Circulation. 110:1202-1208. 2004
- Langerhans Cell Histiocytosis of the Spine in Children. Journal of Bone and Joint Surgery. American volume. 86:1740-1750. 2004
- Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). American Journal of Cardiology. 93:1092-1096. 2004
- Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. American Journal of Cardiology. 93:750-753. 2004
- Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. American Journal of Cardiology. 93:234-237. 2004
- Traumatic aortic transection with intraluminal aortic fat: transesophageal echocardiographic characteristics and implications. Journal of the American Society of Echocardiography. 16:1188-1190. 2003
- Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes. Circulation. 108:1682-1687. 2003
- Clopidogrel in acute coronary syndromes: Can the cost effectiveness improve? Response. Circulation. 108:E56-E56. 2003
- Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.. Journal of Invasive Cardiology. 15 Suppl B:17B-20B. 2003
- Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes. Circulation. 107:966-972. 2003
- Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. Journal of the American College of Cardiology. 41:S79-S88. 2003
- Pharmacological closure of the patent ductus arteriosus.. Images in paediatric cardiology. 5:1-15. 2003
- Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.. Journal of Invasive Cardiology. 14 Suppl E:27E-34E. 2002
- The risks of waiting for cardiac catheterization: a prospective study.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:1233-1240. 2002
- Preemptive Strategy for Ganciclovir Administration Against Cytomegalovirus in Liver Transplantation Recipients. American Journal of Transplantation. 2:955-958. 2002
- Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups. Circulation. 106:1622-1626. 2002
- Case 4—2002 Near-fatal pulmonary embolism in the immediate postoperative period after off-pump coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia. 16:502-507. 2002
- Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects. Journal of the American College of Cardiology. 39:2034-2041. 2002
- Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. American Heart Journal. 143:4A-10A. 2002
- Treatment of acute coronary syndromes - Reply. New England Journal of Medicine. 346:207-208. 2002
- Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention. European Heart Journal. 23:117-123. 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. New England Journal of Medicine. 345:494-502. 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. The Lancet. 358:527-533. 2001
- Stroke in Relation to Cardiac Procedures in Patients With Non–ST-Elevation Acute Coronary Syndrome. Circulation. 104:269-274. 2001
- Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. American Journal of Physiology. Heart and Circulatory Physiology. 280:H2848-H2856. 2001
- Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation. Circulation. 103:643-650. 2001
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. Journal of the American College of Cardiology. 37:475-484. 2001
- Safety Outcomes in Meta-analyses of Phase 2 vs Phase 3 Randomized Trials. Journal of the American Medical Association (JAMA). 285:444-444. 2001
- Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction11Drs. Mehta and Eikelboom were recipients of Heart and Stroke Foundation of Canada Research Fellowship Awards. Professor Yusuf is the recipient of a Medical Research Council of Canada Senior Scientist Award and holds a Heart and Stroke Foundation of Ontario Research Chair.. Journal of the American College of Cardiology. 37:37-43. 2001
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 21:2033-2041. 2000
- Venous Thromboembolism and Cancer. New England Journal of Medicine. 343:1337-1338. 2000
- Management of myocardial infarction: looking beyond efficacy∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.. Journal of the American College of Cardiology. 35:380-381. 2000
- Patterns of angiotensin‐converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure. Clinical Cardiology. 21:261-268. 1998
- Excimer Laser Coronary Angioplasty: The New Approaches to Coronary Intervention (NACI) Experience. American Journal of Cardiology. 80:99K-105K. 1997
- Heart failure between 1986 and 1994: Temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. American Heart Journal. 134:901-909. 1997
- Influence of Gender on In-Hospital Clinical and Angiographic Outcomes and on One-Year Follow-Up In the New Approaches to Coronary Intervention (NACI) Registry. American Journal of Cardiology. 80:26K-39K. 1997
- Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. American Heart Journal. 134:728-736. 1997
- In Vivo Collagen Turnover Following Experimental Balloon Angioplasty Injury and the Role of Matrix Metalloproteinases. Circulation Research. 79:541-550. 1996
- Altered diastolic function in infants of mothers with gestational diabetes: No relation to macrosomia. Pediatric Cardiology. 16:24-27. 1995
- The roles of myoglobin, MB iso-enzyme of creatine phosphokinase and aspartate aminotransferase in serum in the acute phase of myocardial infarction.. Journal of the Indian Medical Association. 92:186-191. 1994
- Effect of beta-blockers on ventilatory function in smokers and non smokers.. The Journal of the Association of Physicians of India. 41:573-575. 1993
- Glanzmann's thrombasthenia--a case report.. Journal of the Indian Medical Association. 89:339-340. 1991
- Clinical Dysautonomia in Patients with Bronchial Asthma. Chest. 98:1408-1413. 1990
- Cardiovascular response to dynamic treadmill exercise in patients with essential hypertension before and after therapy with atenolol or captopril.. The Journal of the Association of Physicians of India. 38:781-784. 1990
- Normokalaemic periodic paralysis as the presenting manifestation of hyperthyroidism.. The Journal of the Association of Physicians of India. 38:296-297. 1990
- Cardiovascular dysautonomia in patients with lepromatous leprosy.. Indian Journal of Leprosy. 62:91-97. 1990
- Congenital afibrinogenaemia.. The Journal of the Association of Physicians of India. 37:668-669. 1989
- Pulmonary Infiltration with Blood Eosinophilia after Scorpion Sting. Chest. 95:691-692. 1989
- Diagnostic significance of pleural fluid eosinophilia during initial thoracocentesis.. The Indian journal of chest diseases & allied sciences. 31:259-264. 1989
- Isolated right ventricular infarction followed by posterior left ventricular infarction after a few days.. Acta Cardiologica. 39:307-312. 1984